Search

everythinglearnresearchcommunity

for

Search:↓

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The symposium concluded that environmental factors significantly contribute to skin aging.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Histone modification is key in treating chronic inflammatory skin diseases.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

The dermal papilla is crucial for hair growth and health, and understanding it could lead to new hair loss treatments.

COVID-19 can cause hair loss, but specialists can help treat it.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Narrowband UVB therapy significantly improved a child's rare skin condition.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.